The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Feb. 27, 2020
Applicant:

Mallinckrodt Pharmaceuticals Ireland Limited, Dublin, IE;

Inventors:

Douglas Stuart Greene, Newtown, PA (US);

Joseph J. Medicis, Syracuse, NY (US);

Jim Potenziano, Binghamton, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/00 (2006.01); G01N 33/84 (2006.01); C12Q 1/6883 (2018.01); A61K 9/00 (2006.01); G01N 33/497 (2006.01);
U.S. Cl.
CPC ...
G01N 33/84 (2013.01); A61K 9/007 (2013.01); A61K 33/00 (2013.01); C12Q 1/6883 (2013.01); G01N 33/497 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); G01N 2800/12 (2013.01);
Abstract

Methods for identifying premature infants at risk for developing bronchopulmonary dysplasia and/or most likely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia (BPD). Methods for treating premature infants identified as at risk and/or likely to benefit are provided. also provided are methods for identifying premature infants that are not at risk for developing bronchopulmonary dysplasia and/or unlikely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia, and methods for avoiding risks of toxicity and undesirable side effects associated with inhaled nitric oxide therapy comprising administering only non-iNO treatment modalities to these infants.


Find Patent Forward Citations

Loading…